NCT02549833 2024-11-22
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
University of California, San Francisco
Phase 1 Completed
University of California, San Francisco
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins